AbbVie’s Skyrizi tops the charts for February’s leading TV drug ad spenders, as Pfizer’s Paxlovid makes its entrance

Insights

Mar 7

Written By Guest User

iSpotFierce Pharma

LIV Golf executive explains delay in reporting Mayakoba viewership, why early reports were ‘incomplete’

Character.AI Reportedly Raises $200 Million — At a $1 Billion Valuation — Amid Artificial Intelligence Boom